Company intelligence / Profile preview

TrueBlue Clinical Research

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

TrueBlue Clinical Research is a leading independent clinical research facility with over 100 years of collective staff experience. The company specializes in multi-specialty Phase II–IV clinical trials and has enrolled over 13,000 patients since its founding. It boasts high recruitment and retention rates (>90%) and leverages advanced eClinical technology for trial management. Recent studies include successful enrollment in dermatological indications such as acne vulgaris and plaque psoriasis

Therapeutic areas: DermatologyCardiovascularOphthalmologyNeurology
Modalities: Small moleculeBiologicDevice
Industry: Contract Research Organization

Beyond the preview

Go deeper on TrueBlue Clinical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TrueBlue Clinical Research.

Explore the full profile